|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.280 USD | +4.92% |
|
+5.79% | -23.35% |
| 05-13 | Lineage Cell Therapeutics, Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-12 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 1.33 | 1.46 | 1.92 |
| Spread/Res. | -3.76% | -12.33% | -33.33% |
| Spread/Supp. | +7.56% | +7.56% | +33.21% |
| Support | 1.19 | 1.19 | 0.9609 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
